Giuseppe
Emeritus
Emergence and control of infectious diseases in China [The Lancet]
The Lancet DOI:10.1016/S0140-6736(08)61365-3
Series, Health System Reform in China
Emergence and control of infectious diseases in China
Prof Longde Wang MD a, Prof Yu Wang MD b, Prof Shuigao Jin PhD c, Prof Zunyou Wu MD
Information, Daniel P Chin MD e, Prof Jeffrey P Koplan MD f and Mary Elizabeth Wilson MD g
Summary
Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control.
China is a major contributor to the worldwide infectious disease burden because of its population size.
The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations.
The ecological interaction of people with animals in China favours the emergence of new microbial threats.
The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases.
To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance.
This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.
Affiliations
a. Ministry of Health, People's Republic of China, Beijing, China
b. Chinese Centre for Disease Control and Prevention, Beijing, China
c. National Centre for Public Health Surveillance and Information Service, Chinese Centre for Disease Control and Prevention, Beijing, China
d. National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
e. Bill & Melinda Gates Foundation China Office, Beijing, China
f. Emory Global Health Institute, Emory University, Atlanta, GA, USA
g. Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
Corresponding Author Information
Correspondence to: Prof Zunyou Wu, National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, 27 Nanwei Road, Beijing 100050, China
-
--
<cite cite="http://www.thelancet.com/journals/lancet/article/PIIS0140673608613653/abstract?isEOP=true">The Lancet</cite>Series, Health System Reform in China
Emergence and control of infectious diseases in China
Prof Longde Wang MD a, Prof Yu Wang MD b, Prof Shuigao Jin PhD c, Prof Zunyou Wu MD
Information, Daniel P Chin MD e, Prof Jeffrey P Koplan MD f and Mary Elizabeth Wilson MD g
Summary
Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control.
China is a major contributor to the worldwide infectious disease burden because of its population size.
The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations.
The ecological interaction of people with animals in China favours the emergence of new microbial threats.
The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases.
To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance.
This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.
Affiliations
a. Ministry of Health, People's Republic of China, Beijing, China
b. Chinese Centre for Disease Control and Prevention, Beijing, China
c. National Centre for Public Health Surveillance and Information Service, Chinese Centre for Disease Control and Prevention, Beijing, China
d. National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
e. Bill & Melinda Gates Foundation China Office, Beijing, China
f. Emory Global Health Institute, Emory University, Atlanta, GA, USA
g. Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
Corresponding Author Information
Correspondence to: Prof Zunyou Wu, National Centre for AIDS/STD Control and Prevention, Chinese Centre for Disease Control and Prevention, 27 Nanwei Road, Beijing 100050, China
-
--